FOR REGULATORY AFFAIRS

The most expensive submission is the one you file twice.

Benchmark your cybersecurity documentation against how the FDA actually reviews it — before you file, not after a rejection.

Check readiness, free Talk to an expert
Cleared for FDA review

We help you build a submission that clears FDA review the first time — every section below is scored and backed by evidence before you file, not patched together after a deficiency letter.

EVERY SECTION, EVIDENCE-BACKED
Threat model & risk analysis
SBOM & vulnerability report
Appendix 1 security controls
Penetration test summary
Cybersecurity labeling

The four gaps still driving deficiency letters in 2026

Medcrypt's own 2026 top-deficiency analysis points to the same recurring, fixable gaps.

01

Penetration testing

Unresolved findings with no documented risk justification.

02

SBOM completeness

Filtered before submission. FDA cross-references public vulnerability databases — a gap questions your whole framework.

03

Appendix 1 controls

Treated as optional guidance when they're a mandatory checklist.

04

Cybersecurity labeling

Insufficient secure-configuration guidance and connectivity disclosure.

WHY IT COSTS MORE NOW

"Close enough" doesn't survive review anymore

Review teams are working through more submissions with less slack in the schedule. A round of deficiency findings doesn't cost the six months it used to — it costs more, because the queue behind you hasn't gotten any shorter.

Filing clean the first time is worth more than it was a year ago.

FDA's first public cybersecurity warning letter
Issued in 2026, with penalties enforceable by injunction, seizure, or criminal prosecution — enforcement is accelerating, not standing still.

Watch readiness become evidence, and evidence become approval.

Score your submission in about thirty minutes and see which eSTAR sections still owe evidence — the same categories FDA actually reviews against.

ESTAR READINESS BY SECTION
78%
Overall readiness
Software Bill of Materials4.1
Threat modeling & risk analysis3.6
Appendix 1 security controls3.9
Penetration test evidence2.8
Cybersecurity labeling3.2

Built by the people who used to review these

Former FDA reviewers and standards authors are behind the readiness scoring and the expert review option — that's not a marketing claim, it's who wrote the workflow.

100% documentation approval rate
200+ projects delivered
13 of 50 leading global MDMs

Built for the submission you're filing right now

FDA audit scans →

Scan your submission package against requirements before you file.

AINN & hold letter response →

Structured, deficiency-by-deficiency support with priority reviewer access.

Document generation →

Threat models and submission docs, drafted from what you already have.

Regulatory intelligence →

Search FDA guidance and deficiency letters in plain language.

Know where you stand in under an hour

Check your readiness for free, or talk through your submission with a former FDA reviewer.

Check readiness, free Talk to an expert